When you face cancer, you want the best possible care that fits your needs.
Quality measures reporting
As part of our Commission on Cancer (CoC) accreditation, we regularly review the quality of cancer care at ProHealth. We analyze our care using:
- Data compiled from the National Cancer Database, which includes information submitted through cancer registries at all Commission on Cancer-accredited hospitals nationwide.
- The CoC’s Cancer Program Practice Profile Reports (CP3R), which allow us to compare our care for certain types of cancer to national standards and continually improve our care to support the best outcomes.
The following 2018 reports reflect data from 2016.
Breast cancer: hormone therapy
Breast cancer: hormone therapy
Hormone therapy is recommended or administered within one year (365 days) of diagnosis for women under 70 with AJCC T1cN0M0, or Stage IB-III hormone receptor positive breast cancer. CoC expected a 90 percent performance rate for this measure.
- ProHealth Care – 100%
- Wisconsin CoC programs – 97%
- All U.S. CoC sites – 90%
Breast cancer: radiation therapy after surgery
Breast cancer: radiation therapy after surgery
Radiation is administered within one year (365 days) of diagnosis for women under 70 receiving breast conservation surgery for breast cancer.
- ProHealth Care – 96%
- Wisconsin CoC programs – 95%
- All U.S. CoC sites – 90%
Breast cancer: needle biopsy
Breast cancer: needle biopsy
Image or palpitation-guided needle biopsy to the primary site is performed to establish a diagnosis of breast cancer.
- ProHealth Care – 94%
- State of Wisconsin – 91%
- All U.S. CoC sites – 89%
Colon cancer: lymph node removal
Colon cancer: lymph node removal
At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer.
- ProHealth Care – 92%
- Wisconsin CoC programs – 93%
- All U.S. CoC sites – 92%